Showing Results for
From:Journal of Experimental & Clinical Cancer Research (Vol. 40, Issue 1) Peer-ReviewedBackground Despite the improvement of relapse-free survival mediated by anti-angiogenic drugs like sunitinib (Sutent[R]), or by combinations of anti-angiogenic drugs with immunotherapy, metastatic clear cell Renal Cell...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it